Atlas Capital Advisors LLC Pfizer Inc Transaction History

Atlas Capital Advisors LLC

$656 Billion
Q3 2024

A detailed history of Atlas Capital Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 2,902 shares of PFE stock, worth $77,541. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,902

Previous 1,102 163.34%

Holding current value

$77,541

Previous $30.8 Million 172.37%

% of portfolio

0.01%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$27.7 - $31.39 $49,860 - $56,502	1,800 Added 163.34%	2,902 $84 Million
Q2 2024 Jul 29, 2024	SELL	$25.26 - $29.6 $15,156 - $17,760	-600 Reduced 35.25%	1,102 $30.8 Million
Q1 2024 Apr 15, 2024	BUY	$25.89 - $29.73 $15,534 - $17,838	600 Added 54.45%	1,702 $47.2 Million
Q4 2023 Feb 15, 2024	SELL	$26.13 - $33.94 $80,375 - $104,399	-3,076 Reduced 73.62%	1,102 $31.7 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $25,768 - $30,120	-803 Reduced 16.12%	4,178 $139 Million
Q2 2023 Aug 15, 2023	SELL	$36.12 - $41.79 $49,990 - $57,837	-1,384 Reduced 21.74%	4,981 $183 Million
Q1 2023 May 16, 2023	SELL	$39.39 - $51.28 $886,550 - $1.15 Million	-22,507 Reduced 77.95%	6,365 $260 Million
Q4 2022 Feb 15, 2023	SELL	$41.75 - $54.5 $57,155 - $74,610	-1,369 Reduced 4.53%	28,872 $1.48 Billion
Q3 2022 Nov 08, 2022	SELL	$43.76 - $53.42 $6,782 - $8,280	-155 Reduced 0.51%	30,241 $1.32 Billion
Q2 2022 Aug 16, 2022	SELL	$46.53 - $55.17 $109,810 - $130,201	-2,360 Reduced 7.2%	30,396 $1.59 Billion
Q1 2022 May 11, 2022	BUY	$45.75 - $56.69 $17,796 - $22,052	389 Added 1.2%	32,756 $1.7 Billion
Q4 2021 Feb 01, 2022	BUY	$41.32 - $61.25 $178,543 - $264,661	4,321 Added 15.41%	32,367 $1.91 Billion
Q3 2021 Oct 28, 2021	BUY	$39.25 - $50.42 $778,249 - $999,727	19,828 Added 241.28%	28,046 $1.21 Million
Q2 2021 Jul 30, 2021	BUY	$35.91 - $40.68 $897 - $1,017	25 Added 0.31%	8,218 $321,000
Q1 2021 May 10, 2021	SELL	$33.49 - $37.77 $60,148 - $67,834	-1,796 Reduced 17.98%	8,193 $296,000
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $132,574 - $168,580	-3,961 Reduced 28.39%	9,989 $367,000
Q3 2020 Oct 23, 2020	SELL	$31.75 - $37.25 $36,830 - $43,210	-1,160 Reduced 7.68%	13,950 $485,000
Q2 2020 Jul 28, 2020	BUY	$30.12 - $36.54 $416,348 - $505,092	13,823 Added 1074.05%	15,110 $468,000
Q1 2020 May 04, 2020	BUY	$27.03 - $38.62 $6,081 - $8,689	225 Added 21.19%	1,287 $39,000
Q3 2019 Nov 01, 2019	SELL	$32.49 - $42.13 $350,859 - $454,961	-10,799 Reduced 91.05%	1,062 $36,000
Q2 2019 Jul 25, 2019	SELL	$36.98 - $41.52 $667,858 - $749,851	-18,060 Reduced 60.36%	11,861 $0
Q1 2019 Apr 29, 2019	SELL	$37.5 - $41.2 $118,500 - $130,192	-3,160 Reduced 9.55%	29,921 $0
Q4 2018 Jan 29, 2019	BUY	$38.47 - $43.86 $1.23 Million - $1.4 Million	32,033 Added 3056.58%	33,081 $1.37 Million
Q2 2018 Jul 30, 2018	SELL	$32.98 - $35.16 $373,861 - $398,573	-11,336 Reduced 91.54%	1,048 $0
Q1 2018 Apr 18, 2018	BUY	$31.91 - $37.02 $395,173 - $458,455	12,384 New	12,384 $0

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.

Account

Atlas Capital Advisors LLC Pfizer Inc Transaction History